Van't Veer LJ - Search Results

1

ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.

Cleton-Jansen AM, van Eijk R, Lombaerts M, Schmidt MK, Van't Veer LJ, Philippo K, Zimmerman RM, Peterse JL, Smit VT, van Wezel T, Cornelisse CJ. Cleton-Jansen AM, et al. BMC Cancer. 2008 Apr 16;8:105. doi: 10.1186/1471-2407-8-105. BMC Cancer. 2008. PMID: 18416817 Free PMC article.

2

A functional assay in yeast for the human estrogen receptor displays wild-type and variant estrogen receptor messenger RNAs present in breast carcinoma.

van Dijk MA, Floore AN, Kloppenborg KI, van 't Veer LJ. van Dijk MA, et al. Cancer Res. 1997 Aug 15;57(16):3478-85. Cancer Res. 1997. PMID: 9270016

3

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.

Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drüsedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van 't Veer LJ, Bakker E, van Ommen GJ, Devilee P. Petrij-Bosch A, et al. Nat Genet. 1997 Nov;17(3):341-5. doi: 10.1038/ng1197-341. Nat Genet. 1997. PMID: 9354803 Free article.

4

A gene-expression signature as a predictor of survival in breast cancer.

van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. van de Vijver MJ, et al. N Engl J Med. 2002 Dec 19;347(25):1999-2009. doi: 10.1056/NEJMoa021967. N Engl J Med. 2002. PMID: 12490681 Free article.

5

Gene expression profiles of primary breast tumors maintained in distant metastases.

Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ. Weigelt B, et al. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15901-5. doi: 10.1073/pnas.2634067100. Epub 2003 Dec 9. Proc Natl Acad Sci U S A. 2003. PMID: 14665696 Free PMC article.

6

Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.

van Beers EH, van Welsem T, Wessels LF, Li Y, Oldenburg RA, Devilee P, Cornelisse CJ, Verhoef S, Hogervorst FB, van't Veer LJ, Nederlof PM. van Beers EH, et al. Cancer Res. 2005 Feb 1;65(3):822-7. Cancer Res. 2005. PMID: 15705879

7

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.

van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, Van't Veer LJ, Tollenaar RA. van Sprundel TC, et al. Br J Cancer. 2005 Aug 8;93(3):287-92. doi: 10.1038/sj.bjc.6602703. Br J Cancer. 2005. PMID: 16052221 Free PMC article.

8

Breast cancer metastasis: markers and models.

Weigelt B, Peterse JL, van 't Veer LJ. Weigelt B, et al. Nat Rev Cancer. 2005 Aug;5(8):591-602. doi: 10.1038/nrc1670. Nat Rev Cancer. 2005. PMID: 16056258 Review.

9

No common denominator for breast cancer lymph node metastasis.

Weigelt B, Wessels LF, Bosma AJ, Glas AM, Nuyten DS, He YD, Dai H, Peterse JL, van't Veer LJ. Weigelt B, et al. Br J Cancer. 2005 Oct 17;93(8):924-32. doi: 10.1038/sj.bjc.6602794. Br J Cancer. 2005. PMID: 16189523 Free PMC article.

10

The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes.

Ruijs MW, Schmidt MK, Nevanlinna H, Tommiska J, Aittomäki K, Pruntel R, Verhoef S, Van't Veer LJ. Ruijs MW, et al. Eur J Hum Genet. 2007 Jan;15(1):110-4. doi: 10.1038/sj.ejhg.5201715. Epub 2006 Sep 27. Eur J Hum Genet. 2007. PMID: 17003841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

389 results

Search Page